CSI Market
Sign In | Register

Celularity Inc (CELU) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CELU Annual Cash Flow →
Cash flow patterns shown here provide context for understanding Celularity Inc's ability to sustain operations and capital deployment.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Sep 30 2025) (Jun 30 2025) (Mar 31 2025) (Dec 31 2024)
Operating Activities
Income-91.72
Depreciation & amortization7.30
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability0.00
Provision For Loan Losses Expensed1.35
Increase (Decrease) in Inventories10.25
Research and Development in Process0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation10.38
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction10.01
Noncash Compensation Expense Related To Private Placement Warrants-
Non Cash Lease Expense0.09
Change In Fair Value Of Contingent Stock Consideration-
Increase Decrease In Right Of Use Assets And Lease Liabilities-
Inventory Reserve For Obsolescence-
Provision For Inventory Obsolescence-
Change In Fair Value Of Debt1.91
Accrued Research Development Software-
Increase Decrease In Operating Lease Liability0.26
Inventory Impairment-
Inventory Impairment Charge-
Issuance Of Common Stock As Consideration For Settlement Agreement-
Issuance Of Common Stock Relating To Debt Extension And Commitment Fee-
Issuance Of Common Stock As Compensation Expense-
Gains Losses On Issuance Of Convertible Note With Warrants2.34
Gains Losses On Forgiveness Of Interest-0.99
Income taxes0.00
Gain (Loss) on Sale of Derivatives-0.07
Accounts Receivable21.00
Increase (Decrease) in Accounts Payable3.13
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.04
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities7.31
Discontinued operations0.00
Net Cash flow from Operating Activities-13.25
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Proceeds From Cash Withdrawn From Trust Account To Pay Franchise And Income Taxes-
Proceeds From Promissory Note-
Proceeds From Sanuwave Convertible Note-
Proceeds From Convertible Note-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire in Process Research and Development0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net-0.12
Other borrowing transactions-0.04
Long-term debt - borrowings10.10
Long-term debt - repayments-8.49
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock2.93
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock2.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net1.29
Proceeds From Sale Of Units Net Of Underwriting Discounts Paid-
Proceeds From Issuance Of Series B Redeemable Convertible Preferred Stock And Warrants Net Of Issuance Costs-
Proceeds From Investment-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents10.98
Proceeds From The Sale Of Common Stock In Atm Offering-
Payments Of At The Market Offering Costs And Commissions-
Proceeds From Issuance Of Senior Secured Bridge Loan And Warrants-
Proceeds From Rwi Senior Secured Bridge Loan And Warrants-
Proceeds From R W I Senior Secured Bridge Loan And Warrants Related Party-
Proceeds From Issuance Of Senior Secured Bridge Loan And Warrants Related Party-
Proceeds From Other Short Term Debt Related Party-
Proceeds From Warrants And Short Term Debt Related Parties-
Repayments Of Short Term Debt Unaffiliated-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities18.65
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-13.25
Total Cash Flow5.40
4 historic quarters locked

Sign in to unlock the full Celularity Inc cash flow history.

Sign In Create Free Account

About Celularity Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20250930)
  • Filed with the SEC: November 14, 2025
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-25-023467

Figures are derived from filed reports and may be restated. Historical data is subject to revision.